Theravance Biopharma, Inc. (TBPH)
Largest Insider Buys in Sector
TBPH Stock Price History Chart
TBPH Stock Performance
About Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical trials for the treatment of rheumatoid arthritis, myelofibrosis, and ulcerative colitis, as well as …
Insider Activity of Theravance Biopharma, Inc.
Over the last 12 months, insiders at Theravance Biopharma, Inc. have bought $20.92M and sold $86,468 worth of Theravance Biopharma, Inc. stock.
On average, over the past 5 years, insiders at Theravance Biopharma, Inc. have bought $20.92M and sold $710,083 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Samaha Eli (10 percent owner) — $62.75M.
The last purchase of 999,800 shares for transaction amount of $7.8M was made by Samaha Eli (10 percent owner) on 2024‑08‑07.
List of Insider Buy and Sell Transactions, Theravance Biopharma, Inc.
| 2024-08-07 | 10 percent owner | 999,800 2.0479% | $7.80 | $7.8M | +4.21% | |||
| 2024-07-10 | Sale | SVP, COMM & MEDICAL AFFAIRS | 4,000 0.0088% | $9.00 | $36,000 | 0.00% | ||
| 2024-05-01 | 10 percent owner | 1.5M 3.0808% | $8.75 | $13.12M | -4.20% | |||
| 2024-02-22 | Sale | SVP, COMM & MEDICAL AFFAIRS | 1,254 0.0025% | $8.71 | $10,922 | +0.29% | ||
| 2023-11-21 | Sale | SVP, COMM & MEDICAL AFFAIRS | 1,378 0.0026% | $10.29 | $14,180 | -12.97% | ||
| 2023-11-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,482 0.0047% | $10.22 | $25,366 | -12.56% | ||
| 2023-10-16 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,482 0.0047% | $9.03 | $22,412 | +0.83% | ||
| 2023-09-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,482 0.0048% | $9.89 | $24,547 | -5.72% | ||
| 2023-08-22 | Sale | SVP, COMM & MEDICAL AFFAIRS | 1,807 0.0034% | $9.47 | $17,112 | -1.27% | ||
| 2023-08-11 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,322 0.004% | $9.99 | $23,197 | -5.77% | ||
| 2023-07-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,322 0.0037% | $9.84 | $22,848 | -3.47% | ||
| 2023-06-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,322 0.0038% | $10.69 | $24,822 | -8.55% | ||
| 2023-06-08 | Sale | SVP, COMM & MEDICAL AFFAIRS | 1,790 0.0028% | $11.13 | $19,923 | -14.26% | ||
| 2023-05-15 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,322 0.0037% | $11.26 | $26,146 | -14.03% | ||
| 2023-04-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,323 0.0037% | $11.88 | $27,597 | -17.70% | ||
| 2023-03-14 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,323 0.0036% | $10.32 | $23,973 | -5.09% | ||
| 2023-03-09 | Sale | SVP, COMM & MEDICAL AFFAIRS | 4,000 0.0063% | $10.20 | $40,800 | -1.51% | ||
| 2023-03-06 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,323 0.0037% | $10.05 | $23,346 | -0.15% | ||
| 2022-12-14 | Sale | CHIEF EXECUTIVE OFFICER | 50,000 0.0741% | $11.19 | $559,500 | -7.40% | ||
| 2022-12-01 | Sale | SVP, RESEARCH & DEVELOPMENT | 2,084 0.0031% | $10.73 | $22,361 | -3.89% |
Insider Historical Profitability
| Samaha Eli | 10 percent owner | 9511150 19.4414% | $8.67 | 2 | 0 | |
| Winningham Rick E | CHIEF EXECUTIVE OFFICER | 1350797 2.7611% | $8.67 | 3 | 1 | +34.06% |
| PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 213180 0.4358% | $8.67 | 1 | 0 | +3.17% |
| GALA RENEE D | SVP, Chief Financial Officer | 171049 0.3496% | $8.67 | 2 | 3 | +44.26% |
| MALKIEL BURTON G | director | 56757 0.116% | $8.67 | 3 | 0 | +20.14% |
Institutional Investor Ownership
| Weiss Asset Management LP | $66.89M | 15.33 | 7.46M | 0% | +$0 | 3.41 | |
| Madison Avenue Partners, LP | $62.9M | 14.42 | 7.01M | 0% | +$0 | 10.3 | |
| Baupost Group | $59.15M | 13.56 | 6.59M | -11.12% | -$7.4M | 1.67 | |
| BlackRock | $37.75M | 8.65 | 4.21M | -8.27% | -$3.4M | <0.01 | |
| Irenic Capital Management Lp | $24.77M | 5.68 | 2.76M | 0% | +$0 | 7.1 |